Debate

Weighing Chickenpox Vaccine for All - page 1, page 2 - New York Times

Now, a chick pox vaccine that has proved both safe and 97 percent effective in trials in children may be about to enter the United States market.  But as eager parents await news of its release, doctors and Federal officials are hesitating about whether to use it.

Chickenpox - Floyd Medical Center

It would be a disservice not to mention that there is still some debate, even among pediatricians, as to whether universal immunization of children younger than 13 years old for chickenpox is appropriate. Most objections boil down to three categories: chickenpox is not a severe enough disease to warrant vaccinating everyone; the vaccine may not give the lifelong immunity that "wild type" chickenpox gives; and the vaccine is to expensive and many insurances do not pay for it.

Chickenpox or Vaccine: A Choice? - Massachusetts Institute of Technology